Applied Genetic Technlogies (Alachua, Fl) a clinical-stage biopharmaceutical company developing gene therapy treatments for Alpha-1 Antitrypsin Deficiency and Leber’s Congenital Amaurosis, closed a $11.8M Series C financing. Participants include InterWest, Intersouth Partners and MedImmune Ventures.